Joni H. Ylostalo
Genetics · 2009
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
Whom Joni H. Ylostalo trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- A. Caplan (in Genetics)
Papers from Joni H. Ylostalo's perspective
Ordered by how strongly the researchers Joni H. Ylostalo trusts endorse each paper. Same corpus, a different order for every researcher.
- Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH) (Bone Marrow Transplantation)
- Why are MSCs therapeutic? New data: new insight (Journal of Pathology)
- Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. (Blood)
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. (Cytotherapy)
- Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells (Proceedings of the National Academy of Sciences of the United States of America)
- Mesenchymal stem cells in health and disease (Nature reviews. Immunology)
- From the laboratory bench to the patient's bedside: An update on clinical trials with mesenchymal stem cells (Journal of Cellular Physiology)
- The Dynamic in vivo Distribution of Bone Marrow-Derived Mesenchymal Stem Cells after Infusion (Cells Tissues Organs)
- Sarcoma Derived from Cultured Mesenchymal Stem Cells (Stem Cells)
- Paracrine mechanisms in adult stem cell signaling and therapy (Circulation Research)